GILD

Gilead Sciences Inc.

Price

$140.45

return (12m)

p/e

18.39

p/bv

7.23

DIVIDEND YIELD

2.36%

GILD price

Gilead Sciences

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment GILD

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

0.00%

3 months

0.00%

1 year

0.00%

2 years

0.00%

5 years

0.00%

10 years

0.00%

Fundamentals GILD

Valuation

P/E

18.39

Sector -4.15

Industry -4.15

P/BV

7.23

Sector 2.06

Industry 2.06

P/Revenue (PSR)

5.70

Sector -4.16

Industry -4.16

EV/EBITDA

52.06

Sector -241.86

Industry -241.86

EV/EBIT

64.78

Sector -671.75

Industry -671.75

P/EBITDA

11.70

Sector -4.30

Industry -4.30

P/EBIT

14.44

Sector -4.35

Industry -4.35

P/Total Assets

3.01

Sector 1.46

Industry 1.46

P/Net Current Assets

-11.93

Sector -12.67

Industry -12.67

P/Working Capital

18.49

Sector -12.58

Industry -12.58

EPS

7.42

Sector -2.19

Industry -2.19

BVPS

18.87

Sector 1.92

Industry 1.92

Efficiency

Gross Margin

79.35%

Sector 36.44%

Industry 36.44%

EBITDA Margin

50.42%

Sector -16,748.51%

Industry -16,748.51%

EBIT Margin

40.52%

Sector -4,256,846.44%

Industry -4,256,846.44%

Operating Margin

40.02%

Sector -38.78%

Industry -38.78%

Net Profit Margins

30.99%

Sector -39.93%

Industry -39.93%

Asset Turnover

0.12

Sector 0.03

Industry 0.03

Profitability

ROE

39.33%

Sector -67.01%

Industry -67.01%

ROA

16.38%

Sector -66.28%

Industry -66.28%

ROIC

18.49%

Sector -2,917.75%

Industry -2,917.75%

Dividends

Dividend yield

2.36%

Sector -

Industry -

Payout

43.40%

Sector -

Industry -

Debt

Current Ratio

1.97

Sector 2.90

Industry 2.90

Net Debt / EBITDA

3.77

Sector -12,252,405.04

Industry -12,252,405.04

Net Debt / EBIT

4.69

Sector -3.79

Industry -3.79

Net Debt / Equity

0.56

Sector -33,290.93

Industry -33,290.93

Gross Debt / Equity

0.89

Sector 0.00

Industry 0.00

Equity/Assets

0.42

Sector 0.42

Industry 0.42

Liabilities/Assets

0.58

Sector 0.39

Industry 0.39

Growth

5Y Revenue CAGR

1.72%

Sector -

Industry -

5Y Earnings CAGR

8.16%

Sector -

Industry -

FAIR VALUE OF Gilead Sciences ACCORDING TO BENJAMIN GRAHAM

Graham's Fair Value

The Fair Value formula was created by Benjamin Graham to identify stocks with appreciation potential or that are being traded for less than they are worth. Graham was one of the greatest investors in history and Warren Buffett’s mentor.

Current price

$140.45

Fair Value

$56.13

Upside Return potential.

-60.04%

See Graham's ranking

Because it considers equity value in its calculation, this formula may not work well for technology companies.

This is not a buy/sell recommendation; the fair value calculation takes into account only the formula created by Benjamin Graham, published in the book The Intelligent Investor.

Fundamentals GILD

DRAG THE FRAME TO SEE MORE DATA

Assets	Price (US$)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
GILD Gilead Sciences Inc.	$140.45	39.13%	2.36%	18.39	7.23	39.33%	30.99%
AZN AstraZeneca PLC	$204.64	53.45%	1.89%	25.20	5.52	21.93%	17.19%
JNJ Johnson & Johnson	$240.16	62.69%	2.08%	28.83	0.00	-%	21.48%
NBIX Neurocrine Biosciences Inc.	$130.81	43.95%	0.00%	25.46	5.00	19.62%	21.55%
ABEO Abeona Therapeutics Inc.	$5.19	12.83%	0.00%	6.09	2.78	45.63%	100.00%
PFE Pfizer Inc.	$27.11	32.71%	6.97%	18.76	1.55	8.29%	11.83%
ABBV AbbVie Inc.	$210.26	25.08%	2.61%	125.53	-69.01	-54.98%	5.79%
ABUS Arbutus Biopharma Corporation	$4.35	38.54%	0.00%	5.66	3.50	61.77%	83.94%
ACAD ACADIA Pharmaceuticals Inc.	$22.02	51.03%	0.00%	11.55	3.48	30.10%	34.30%
ADMA ADMA Biologics Inc.	$10.49	-45.93%	0.00%	12.58	5.33	42.37%	32.43%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

GILD Historical Dividends

current DY: 2.36%

5-year average DY: 3.67%

DRAG THE FRAME TO SEE MORE DATA

type	Ex - Dividend Date	payment date	value
Dividends	03/13/2026	03/30/2026	0.82000000
Dividends	12/15/2025	12/30/2025	0.79000000
Dividends	09/15/2025	09/29/2025	0.79000000
Dividends	06/13/2025	06/27/2025	0.79000000
Dividends	03/14/2025	03/28/2025	0.79000000
Dividends	12/13/2024	12/30/2024	0.77000000
Dividends	09/13/2024	09/27/2024	0.77000000
Dividends	06/14/2024	06/27/2024	0.77000000
Dividends	03/15/2024	03/28/2024	0.77000000
Dividends	12/15/2023	12/28/2023	0.75000000
Dividends	09/15/2023	09/28/2023	0.75000000
Dividends	06/15/2023	06/29/2023	0.75000000
Dividends	03/15/2023	03/30/2023	0.75000000
Dividends	12/15/2022	12/29/2022	0.73000000
Dividends	09/15/2022	09/29/2022	0.73000000
Dividends	06/15/2022	06/29/2022	0.73000000
Dividends	03/15/2022	03/30/2022	0.73000000
Dividends	12/15/2021	12/30/2021	0.71000000
Dividends	09/15/2021	09/29/2021	0.71000000
Dividends	06/15/2021	06/29/2021	0.71000000
Dividends	03/15/2021	03/30/2021	0.71000000
Dividends	12/15/2020	12/30/2020	0.68000000
Dividends	09/15/2020	09/29/2020	0.68000000
Dividends	06/12/2020	06/29/2020	0.68000000
Dividends	03/13/2020	03/30/2020	0.68000000
Dividends	12/13/2019	12/30/2019	0.63000000
Dividends	09/13/2019	09/27/2019	0.63000000
Dividends	06/14/2019	06/27/2019	0.63000000
Dividends	03/15/2019	03/28/2019	0.63000000
Dividends	12/14/2018	12/28/2018	0.57000000
Dividends	09/14/2018	09/27/2018	0.57000000
Dividends	06/15/2018	06/28/2018	0.57000000
Dividends	03/16/2018	03/29/2018	0.57000000
Dividends	12/15/2017	12/28/2017	0.52000000
Dividends	09/15/2017	09/28/2017	0.52000000
Dividends	06/16/2017	06/29/2017	0.52000000
Dividends	03/16/2017	03/30/2017	0.52000000
Dividends	12/15/2016	12/29/2016	0.47000000
Dividends	09/16/2016	09/29/2016	0.47000000
Dividends	06/16/2016	06/29/2016	0.47000000
Dividends	03/16/2016	03/30/2016	0.43000000
Dividends	12/16/2015	12/30/2015	0.43000000
Dividends	09/16/2015	09/29/2015	0.43000000
Dividends	06/16/2015	06/29/2015	0.43000000

ABOUT Gilead Sciences

Gilead Sciences Inc.

Average Investor10 user rating

4.0 (0 people)

States of America

39 years

Founded: 1987

1992

Time since IPO - 34 years

13.600

Employees

Gilead Sciences Inc. (States of America) is listed on the Nasdaq and has a market capitalization of $169.47 billion, with shareholders equity totaling $23.43 billion.

The company employs approximately 13.600 people and operates in the Healthcare sector, within the Biotecnologia industry.

Over the past 12 months, Gilead Sciences Inc. reported $29.73 billion in revenue, generating net income of $9.22 billion.

Key financial metrics include a P/E ratio of 18.39, a price-to-book (P/B) ratio of 7.23, and a trailing twelve-month dividend yield of 2.36%.

The company trades under the ticker GILD.

Market cap

$169.47 billion

Net worth

$23.43 billion

$23,431,000,000.00

Assets

$56.28 billion

$56,278,000,000.00

Total Shares Outstanding

1.24 billion

1,242,000,000

Average Daily Trading Volume

$7.93 million

$7,926,132.00

Sector

Healthcare

Industry

Biotecnologia

GILD

revenue by Business Segment Gilead Sciences

GILD revenue and profits

Financial Results GILD

DRAG THE FRAME TO SEE MORE DATA

GILD cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

BFRA - Biofrontera

$- -0,00% (12M)

P/E

0.00

0.00%

ROE

-893.55%

P/BV

0.00

MCK - McKesson

$862.96 22,54% (12M)

P/E

21.66

0.39%

ROE

-570.98%

P/BV

-123.68

CAH - Cardinal Health

$214.95 38,63% (12M)

P/E

34.90

0.89%

ROE

-58.20%

P/BV

-20.31

JNJ - Johnson & Johnson

$240.16 47,25% (12M)

P/E

28.83

2.08%

ROE

P/BV

0.00

MRK - Merck & Co.

$119.96 46,43% (12M)

P/E

35.53

2.62%

ROE

19.45%

P/BV

6.91

AZN - AstraZeneca

$204.64 40,78% (12M)

P/E

25.20

1.89%

ROE

21.93%

P/BV

5.52

ABBV - AbbVie

$210.26 15,08% (12M)

P/E

125.53

2.61%

ROE

-54.98%

P/BV

-69.01

NVO - Novo Nordisk

$39.32 --40,26% (12M)

P/E

11.83

3.68%

ROE

60.40%

P/BV

7.14